Quantcast

Latest Ciprofloxacin Stories

Z-Pack Antibiotic Warning From The FDA
2013-03-13 05:35:24

redOrbit Staff & Wire Reports - Your Universe Online A commonly-prescribed antibiotic could trigger potentially fatal irregular heart rhythms in some patients, officials from the US Food and Drug Administration (FDA) warned on Tuesday. Azithromycin, which is commonly sold as Zithromax or Zmax and is sometimes referred to as a “Z-Pack,” could cause the condition in patients who have an elevated risk of developing cardiovascular problems, reports Deborah Kotz of the Boston...

2012-06-21 02:05:05

A potential new approach for treating urinary tract infections (UTIs) – which affect millions of people annually – without traditional antibiotics is being reported in ACS' Journal of Medicinal Chemistry. It involves so-called FimH antagonists, which are non-antibiotic compounds and would not contribute to the growing problem of antibiotic resistance bacteria. Beat Ernst and colleagues explain that antibiotics are the mainstay treatment for UTIs. Bacteria, however, are...

2012-04-30 19:51:34

In a surveillance study of over 12 million bacteria, investigators at The George Washington University and Providence Hospital found E. coli antimicrobial resistance to ciprofloxacin, the most commonly prescribed antimicrobial for urinary tract infections in the U.S., increased over five-fold from 2000 to 2010. In addition, nearly one in four isolates in 2010 were resistant to trimethoprim-sulfamethoxazole (Bactrim®), the second most commonly prescribed drug for this infection. "Our...

2012-03-28 23:00:55

Last month, the California Supreme Court agreed to review a class-action lawsuit over the drug Cipro. Cipro is a brand name for ciprofloxacin, of a class of antibiotic drugs known as fluoroquinolones. Manufactured originally by Bayer, it is used for many types of infections including pneumonia, skin infections, urinary tract infections, bronchitis and joint infections, among others. The lawsuit argues that it was illegal for Bayer to pay a competitor to stay out of the market as part of a...

2012-03-28 10:52:40

Combining common antibiotics with additional compounds could make previously resistant bacteria more susceptible to the same antibiotics. 'Resuscitation' of existing antibiotics has the potential to make infections caused by multidrug-resistant bacteria easier to control, reducing antibiotic usage and levels of antimicrobial resistance, say scientists presenting their work at the Society for General Microbiology's Spring Conference in Dublin this week. Researchers from University College...

2012-02-13 06:40:52

(Ivanhoe Newswire) -- A recent study has discovered that short-term use of the antibiotic cefpodoxime for treatment of bladder infections (uncomplicated cystitis) in women did not meet criteria for achieving clinical cure compared to ciproflaxacin, a drug classified as fluoroquinolone antibiotics, that is under concern for overuse and resulting in an increase in resistance rates. While fluoroquinolone has minimal adverse drug reactions when used in a 3-day regimen and high efficacy rates,...

2012-02-07 23:19:50

Short-term use of the antibiotic cefpodoxime for the treatment of women with uncomplicated cystitis (bladder infection) did not meet criteria for noninferiority for achieving clinical cure compared with ciprofloxacin, a drug in the fluoroquinolone class of antibiotics for which there have been concerns about overuse and a resulting increase in resistance rates, according to a study in the February 8 issue of JAMA. The criteria for noninferiority was if the efficacy of cefpodoxime had been...

2011-11-30 10:50:15

In research at SRI International, scientists evaluating new drug targets against tuberculosis (TB) recently validated the preclinical effectiveness of a target that could rapidly eliminate infections and potentially shorten treatment time. The new drug target is a protein called DNA gyrase B, found in bacteria that cause TB infections. DNA gyrase is an enzyme consisting of two subunits: gyrase A and gyrase B. Although gyrase A is often the target of antibiotics, such as ciprofloxacin,...

2011-06-20 14:44:00

SILVER SPRING, Md., June 20, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the first generic versions of Levaquin (levofloxacin), an antibiotic approved to treat certain infections in people ages 18 and older. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Levofloxacin is used to treat mild, moderate, or severe bacterial infections of the skin, sinuses, kidneys, bladder, and prostate caused by specific germs. It also is used to treat...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related